AN2 Therapeutics Inc <ANTX.O>: Guggenheim initiates coverage with buy rating; target price $9
ANTX•Related News
Credicorp posts transcript of Q2 2026 earnings call
BAP•
General Atlantic picks JPMorgan to lead revived IPO effort, source says
JPM•
JLL arranges sale of 1.12 million-sq-ft Subaru distribution facility in Indiana to LaSalle Investment Management
JLL•
Fastenal EVP Strategy and Communication Donnalee Kathleen Papenfuss sells 9,258 shares for $475,875.95
FAST•
NY judge tosses Uber lawsuit claiming lawyers inflated injury claims
UBER•